Auna S.A. Accelerates Expansion of OncoMexico Network Across Mexico Through Strategic Healthcare Partnerships and Major Investment Plans
Auna S.A. (“Auna” or the “Company”), a premier integrated healthcare services provider in Latin America with established operations in Mexico, Peru, and Colombia, has announced a significant expansion of its insurance and care delivery network in Mexico. This strategic move substantially enhances Auna’s national footprint and reinforces its commitment to delivering high-quality, accessible, and coordinated oncology and specialty care through its OncoMexico platform. The expansion is being driven by a series of high-impact partnerships with some of Mexico’s most respected private medical institutions, alongside a bold investment roadmap and proactive engagement with capital markets.
At the core of this expansion is Auna’s collaboration with leading healthcare providers across Mexico’s key metropolitan areas. The Company has formalized strategic alliances with renowned institutions including Médica Sur in Mexico City—a nationally recognized academic medical center known for its excellence in oncology and complex care; Hospital San Javier in Guadalajara, a major private hospital with advanced diagnostic and therapeutic capabilities; Simnsa in Tijuana, a prominent healthcare group serving the northern border region; and Centros Médicos de Especialidades Cd Juárez in Ciudad Juárez, which provides critical specialty services in a strategically important border city. In addition, Auna has secured partnerships with four additional medical centers in León, Mérida, Querétaro, and Puebla—cities that represent some of Mexico’s fastest-growing economic and population hubs.
Through these collaborations, Auna’s OncoMexico members now gain seamless access to integrated, high-standard care across a geographically diverse and clinically robust network. This nationwide coverage ensures that patients—particularly those undergoing complex treatments such as cancer therapy—can receive consistent, coordinated, and timely care regardless of their location within Mexico. The integration of these top-tier providers into Auna’s ecosystem not only expands physical access but also elevates the overall quality and continuity of care by aligning clinical protocols, data sharing, and patient management practices under Auna’s integrated care model.
Complementing its physical network expansion, Auna has also partnered with Welbe, a cutting-edge digital health platform operating nationwide in Mexico. Welbe empowers patients to easily schedule and manage preventive care appointments, track health metrics, and engage proactively with their care teams through a user-friendly mobile interface. This digital integration significantly enhances patient engagement, improves adherence to screening and follow-up protocols, and supports Auna’s broader mission of shifting care toward prevention and early intervention—particularly critical in oncology, where early detection dramatically improves outcomes.
To sustain and accelerate this growth trajectory, Auna has unveiled an ambitious investment plan totaling approximately US$500 million over the next three to five years, focused on Mexico’s principal urban centers. These funds will be deployed to build new clinical facilities, upgrade existing infrastructure, expand diagnostic and therapeutic capacity (including advanced oncology services such as radiation therapy and cellular therapies), and deepen the technological and operational integration of its care delivery model. The investment underscores Auna’s long-term confidence in the Mexican healthcare market and its commitment to serving local communities with world-class, patient-centered care.
In parallel with its operational expansion, Auna is actively engaging with the financial community to secure the capital necessary to support this growth while optimizing its balance sheet. The Company plans to hold meetings with debt and equity investors in the coming weeks and months as it evaluates a range of financing alternatives. These may include debt issuances, equity offerings, or a combination of both, with the dual objectives of funding its US$500 million investment program and refinancing a portion of its existing indebtedness to strengthen its capital structure. Auna has indicated that it aims to maintain a prudent leverage profile, targeting a Net Debt-to-EBITDA ratio of no more than 3.0x upon completion of these financings. However, the Company cautioned that there is no assurance that any proposed financing will be successfully completed, as market conditions and investor appetite may influence outcomes.
This strategic financial planning comes on the heels of another significant milestone: the recent listing of Auna’s Class A shares on the Lima Stock Exchange (BVL). The listing enhances the Company’s visibility among institutional investors and improves liquidity for shareholders. Building on this momentum, Auna has announced that it now meets the eligibility criteria for inclusion in three indices managed by MSCI (Morgan Stanley Capital International)—a development that could attract passive investment flows and further broaden its investor base. While inclusion in these indices is not guaranteed and remains subject to MSCI’s independent review process, Auna expressed optimism about the potential recognition, which would reflect the Company’s growing scale, governance standards, and regional leadership in healthcare delivery.
The expansion of the OncoMexico network represents more than just geographic growth—it signals Auna’s evolution into a truly integrated health system in Mexico. By combining physical access through elite provider partnerships, digital engagement via platforms like Welbe, and substantial capital investment, Auna is constructing a comprehensive care continuum that addresses the full spectrum of patient needs—from prevention and diagnosis to treatment and survivorship. This model is particularly well-suited to the demands of modern oncology care, which requires multidisciplinary coordination, precision diagnostics, and personalized treatment plans.
Moreover, Auna’s strategy aligns with broader trends in Latin American healthcare, where rising middle-class populations, increasing cancer incidence, and growing demand for private, high-quality services are driving market transformation. By positioning itself at the intersection of clinical excellence, technological innovation, and financial sustainability, Auna is well-placed to capture significant value in this dynamic landscape.
The Company emphasized that this press release does not constitute an offer to sell, or a solicitation of an offer to buy, any securities. It further clarified that any future securities offerings will comply fully with applicable regulations, including the registration requirements of the U.S. Securities Act of 1933, as amended, and will not be made in any jurisdiction where such activity would be unlawful without proper registration or qualification.
